# FASLODEX

NDC: 0310-0720
Generic name: Fulvestrant
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20101101

FDA application: NDA021344

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0720"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0720
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7